Table: Fuji Pharmaceutical -2018/19 parent results

Fuji Pharma

08/11/2019 08:00

Nov 8 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2019    Sep 30, 2018   Sep 30, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           33.74           35.43          31.71        15.60    
               (-4.8 pct)      (+7.4 pct)     (-6.0 pct)    (-9.8 pct) 
  Operating        3.85            4.06                                
               (-5.1 pct)      (-2.0 pct)                              
  Recurring        3.97            4.23           2.64         1.24    
               (-6.3 pct)      (-5.4 pct)     (-33.4 pct)  (-50.7 pct) 
  Net              2.84            3.23           1.86       874 mln   
               (-12.1 pct)     (+0.0 pct)     (-34.5 pct)  (-49.4 pct) 
  EPS           93.10 yen      108.02 yen      59.76 yen    28.06 yen  
  Ann Div       29.00 yen                      29.00 yen               
  -Q2 Div       14.00 yen       28.00 yen      14.00 yen               
  -Q4 Div       15.00 yen       14.00 yen      15.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T